Get the Stockscreener App
5.84
6.38%
0.35
Pre-market:
5.90
0.06
+1.03%
Certara Inc stock is traded at $5.84, with a volume of 17.21M.
It is up +6.38% in the last 24 hours and up +12.09% over the past month.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
See More
Previous Close:
$5.49
Open:
$5.41
24h Volume:
17.21M
Relative Volume:
4.14
Market Cap:
$908.50M
Revenue:
$419.75M
Net Income/Loss:
$-15.10M
P/E Ratio:
-61.28
EPS:
-0.0953
Net Cash Flow:
$63.10M
1W Performance:
+5.42%
1M Performance:
+12.09%
6M Performance:
-34.31%
1Y Performance:
-48.86%
1-Day Range:
$5.41
$5.915
1-Week Range:
$5.305
$5.915
52-Week Range:
$4.45
$13.88
Certara Inc Stock (CERT) Company Profile
Name
Certara Inc
Sector
Industry
Phone
(415) 237-8272
Address
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Compare CERT vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
5.84 | 908.50M | 419.75M | -15.10M | 63.10M | -0.0953 |
VEEV
Veeva Systems Inc
|
171.36 | 27.84B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
68.98 | 13.54B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
56.14 | 10.08B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
88.46 | 7.40B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
78.97 | 6.11B | 646.34M | -512.40M | 202.76M | -6.6871 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-27-26 | Downgrade | Craig Hallum | Buy → Hold |
| Jan-06-26 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Nov-21-25 | Initiated | Rothschild & Co Redburn | Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Sep-29-25 | Initiated | Craig Hallum | Buy |
| Jul-03-25 | Resumed | Morgan Stanley | Equal-Weight |
| May-08-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Feb-27-25 | Initiated | TD Cowen | Buy |
| Sep-27-24 | Upgrade | UBS | Neutral → Buy |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-04-24 | Initiated | JMP Securities | Mkt Perform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Aug-22-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-10-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Apr-03-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-08-22 | Initiated | Berenberg | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-01-22 | Initiated | Piper Sandler | Overweight |
| Jan-11-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-23-21 | Initiated | Robert W. Baird | Outperform |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-06-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-05-21 | Initiated | BofA Securities | Buy |
| Jan-05-21 | Initiated | Credit Suisse | Neutral |
| Jan-05-21 | Initiated | Jefferies | Hold |
| Jan-05-21 | Initiated | William Blair | Outperform |
View All
Certara Inc Stock (CERT) Latest News
Enterprise value to EBITDA forward of Certara, Inc. – NASDAQ:CERT - TradingView
Enterprise value to EBIT forward of Certara, Inc. – NASDAQ:CERT - TradingView
Price to book forward of Certara, Inc. – NASDAQ:CERT - TradingView
Price to book forward of Certara, Inc. – BMV:CERT - TradingView
Price to earnings forward of Certara, Inc. – BMV:CERT - TradingView
[Latest] Global In Silico Clinical Trials Market Size/Share Worth USD 8.94 Billion by 2035 at a 15.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc.CERT - PR Newswire
Certara, Inc. Actuals & Estimates (NASDAQ:CERT) - TradingView
CERT Forecast — Price Target — Prediction for 2027 - TradingView
Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-Risk Investment and Accelerate Development - marketscreener.com
CERT Stock Slides As Certara Faces Probes And CFO Exit - timothysykes.com
Certara StockLaw Firm Launches Investigation After Share Price Slide - Ad-hoc-news.de
Certara names Faiz Mohammed interim CFO as John Gallagher steps down - MSN
Certara (CERT) Stock Sees Fair Value Edges Lower As Analysts Trim Targets - Yahoo Finance
Bragar Eagel & Squire, P.C. is Investigating Certara, Inc. - GlobeNewswire
(CERT) Volatility Zones as Tactical Triggers - Stock Traders Daily
Certara, Inc. Shareholders Are Encouraged to Reach Out to - GlobeNewswire
Certara Appoints Interim CFO Amid Leadership Transition - The Globe and Mail
Certara CFO John Gallagher to resign, reaffirms 2026 guidance By Investing.com - Investing.com India
SMID Core Equity Portfolio's Certara Inc(CERT) Holding History - GuruFocus
Certara (CERT) CFO John Gallagher Announces Resignation, Interim Successor Appointed - GuruFocus
Certara Announces CFO Transition, Names Interim CFO, and Reaffirms 2026 Financial Guidance - Minichart
Certara (CERT) CFO John Gallagher to Resign in 2026, Interim Suc - GuruFocus
Certara CFO John Gallagher to resign, reaffirms 2026 guidance - Investing.com
Certara Announces CFO Transition - The Manila Times
CFO transition at Certara (NASDAQ: CERT) as company reaffirms 2026 guidance - Stock Titan
Certara names interim CFO as John Gallagher plans July exit - Stock Titan
Certara Inc (CERT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Certara Inc (CERT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Certara Inc (CERT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Certara Inc (CERT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Certara Inc (CERT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Certara Inc (CERT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Certara Inc (CERT) Institutional Confidence - TradingKey
Certara Inc (CERT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Certara Inc (CERT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Certara, Inc. Hits Day High with 16.12% Surge in Stock Price - MarketsMojo
Is It Time To Consider Buying Certara, Inc. (NASDAQ:CERT)? - simplywall.st
symbol__ Stock Quote Price and Forecast - CNN
Certara (CERT) Valuation Boosted by Simulations Plus Acquisition - GuruFocus
Certara outlines AI push, cost cuts and new growth engines at Jefferies conference - MSN
CERT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Certara Inc. (CERT) Q1 2026 Earnings: EPS Miss Weighs on Shares as Biosimulation Demand Remains SteadySpecial Dividend Alert - newsline.com
CERT Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesMid-Term Outlook - newsline.com
Certara Q1 2026 Earnings: EPS Misses Estimates, Stock Slips as Revenue Details Remain UnclearDividend Increase Stocks - newsline.com
Certara Inc. (CERT) Q1 2026 Earnings: EPS Misses Estimates, Shares Rise on Mixed SignalsDividend Earnings Report - newsline.com
CERT Investors Have Opportunity to Join Certara, Inc. Fraud Inve - GuruFocus
CERT Investors Have Opportunity to Join Certara, Inc. Fraud Investigation with the Schall Law Firm - Morningstar
Certara Company Profile & Introduction - Moomoo
Certara Inc Stock (CERT) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):